High-risk medications are classified as such due to their narrow therapeutic range and potential for serious adverse drug events (ADE). This review analyzes the results of randomized clinical trials to identify effective interventions to reduce ADE related to high-risk medications in hospitals. The most cited medications were warfarin, cyclophosphamide, and cyclosporine. The most common intervention was developing protocols for safe use.